Marco Gerling
Principal Researcher
E-mail: marco.gerling@ki.se
Visiting address: KI, inst för klinisk vetenskap,intervention och teknik, 14186 Huddinge
Postal address: H9 Klinisk vetenskap, intervention och teknik, H9 CLT Kirurgi o onkologi Gerling, 171 77 Stockholm
About me
- I am group leader at the Department of Biosciences and Nutrition at Karolinska Institutet. I work 50% as clinician in oncology at Karolinska University Hospital, Tema Cancer.
Visit our lab page for more information!
[1] https://ki.se/en/bionut/cancer-cell-invasion
Research
- My research centers around the role of non-cancer cells in liver metatases.
Interactions with non-cancerous cell in the tumor microenvironment modify tumor cell behaviour, such as proliferation and differentiation. Clinically,
the nature of these contacts impacts prognosis and can be used to predict treatment response.
With my research, I want to understand the intricate mechanisms of intercellular communication between tumor cells and non-tumor cells.
The main goals of our lab are to identify predictive and prognostic markers, and to contribute to the development of novel, microenvironment-based therapies.
Articles
-
Journal article: CURRENT OPINION IN CELL BIOLOGY. 2024;86:102315
-
Article: NPJ BREAST CANCER. 2023;9(1):100
-
Journal article: BJC REPORTS. 2023;1(1):19
-
Journal article: ANNALS OF ONCOLOGY. 2023;34:s276-s277
-
Article: NATURE COMMUNICATIONS. 2023;14(1):5024
-
Journal article: CANCER RESEARCH. 2023;83(5):p6-14-06-p6-14-06
-
Article: EJSO. 2022;48(7):1656-1663
-
Article: FRONTIERS IN ONCOLOGY. 2022;12:965182
-
Article: NEOPLASIA. 2021;23(12):1300-1306
-
Article: TRANSGENIC RESEARCH. 2021;30(5):701-707
-
Article: NATURE METHODS. 2021;18(8):912-920
-
Article: ELIFE. 2020;9:e46756
-
Article: ONCOGENE. 2019;38(28):5670-5685
-
Article: MUCOSAL IMMUNOLOGY. 2019;12(3):656-667
-
Journal article: GASTROENTEROLOGY. 2019;156(6):s-445
-
Article: ESMO OPEN. 2019;4(6):e000607
-
Article: BMJ OPEN GASTROENTEROLOGY. 2018;5(1):e000217
-
Article: DEVELOPMENTAL BIOLOGY. 2017;429(1):132-146
-
Article: NATURE CELL BIOLOGY. 2016;18(12):1346-1356
-
Article: NATURE COMMUNICATIONS. 2016;7:12321
-
Article: NATURE COMMUNICATIONS. 2016;7:11314
-
Article: CLINICAL SCIENCE. 2015;129(3):281-290
-
Article: THERANOSTICS. 2014;4(6):604-613
-
Article: INFLAMMATORY BOWEL DISEASES. 2013;19(4):691-703
-
Article: PLOS ONE. 2011;6(7):e22114
-
Article: ANNALS OF SURGERY. 2010;252(1):74-83
- Show more
All other publications
-
Review: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023;11(3):e005841
-
Other: CASE REPORTS IN ONCOLOGY. 2023;16(1):525-531
-
Review: BRITISH JOURNAL OF CANCER. 2022;127(6):988-1013
-
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(3):1025
-
Review: ANGIOGENESIS. 2020;23(1):43-54
-
Conference publication: ACTA PHYSIOLOGICA. 2019;227
-
Preprint: BIORXIV. 2018
-
Preprint: SSRN ELECTRONIC JOURNAL. 2018
-
Corrigendum: NATURE COMMUNICATIONS. 2016;7:12936
Grants
-
Swedish Research Council1 January 2019 - 31 December 2024
-
Deutsche Forschungsgemeinschaft1 January 2011 - 31 December 2014
Employments
- Principal Researcher, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2024-
- Principal Researcher, Department of Biosciences and Nutrition, Karolinska Institutet, 2022-2024